mifepristone has been researched along with atosiban in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Billi, S; Farina, MG; Franchi, AM; Guadagnoli, T; Leguizamón, G; Ribeiro, ML; Weissmann, C | 1 |
| Boatwright, N; Crockett, SL; De, D; Hansen, CJ; Herington, JL; Newton, J; Paria, BC; Reese, J; Rogers, JH; Simpson, CL; Siricilla, S; Sulikowski, GA; Waterson, AG | 1 |
3 other study(ies) available for mifepristone and atosiban
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Secretory and cytosolic phospholipase A2 activities and expression are regulated by oxytocin and estradiol during labor.
Topics: Animals; Cytosol; Dinoprost; Estradiol; Estrogen Antagonists; Female; Gene Expression; Isoenzymes; Labor, Obstetric; Mifepristone; Oxytocin; Phospholipases A2; Pregnancy; Progesterone; Rats; Rats, Wistar; Receptors, Oxytocin; Reverse Transcriptase Polymerase Chain Reaction; Tamoxifen; Uterus; Vasotocin | 2007 |
Arrest of mouse preterm labor until term delivery by combination therapy with atosiban and mundulone, a natural product with tocolytic efficacy.
Topics: Animals; Biological Products; Female; Humans; Infant, Newborn; Mice; Mifepristone; Nifedipine; Obstetric Labor, Premature; Premature Birth; Tocolytic Agents | 2023 |